Sintilimab: another effective immune checkpoint inhibitor in classical Hodgkin lymphoma

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)e2-e3
JournalThe Lancet Haematology
Volume6
Issue number1
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Hematology

Cite this